These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16039889)

  • 21. Medical management of renal hyperparathyroidism. Pulse treatment with vitamin D metabolites or not?
    Reichel H
    Nephrol Dial Transplant; 1994; 9(10):1368-70. PubMed ID: 7816246
    [No Abstract]   [Full Text] [Related]  

  • 22. [Renal osteodystrophy and growth in children undergoing CAPD].
    Ito T; Horiike S; Iitaka K
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of vitamin D in the pathogenesis of renal osteodystrophy].
    Nakanishi S; Fukagawa M
    Clin Calcium; 2004 Sep; 14(9):15-20. PubMed ID: 15577104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brown tumor at the jaw in patients with secondary hyperparathyroidism due to chronic renal failure.
    Pechalova PF; Poriazova EG
    Acta Medica (Hradec Kralove); 2013; 56(2):83-6. PubMed ID: 24069663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.
    Klaus G; Watson A; Edefonti A; Fischbach M; Rönnholm K; Schaefer F; Simkova E; Stefanidis CJ; Strazdins V; Vande Walle J; Schröder C; Zurowska A; Ekim M;
    Pediatr Nephrol; 2006 Feb; 21(2):151-9. PubMed ID: 16247644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW; Elangovan L
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [K/DOQI clinical practice guidelines for management of renal osteodystrophy in predialysis patients].
    Okada N; Tsubakihara Y
    Clin Calcium; 2004 May; 14(5):698-706. PubMed ID: 15577030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD).
    Goldsmith DJ; Massy ZA; Brandenburg V
    Semin Nephrol; 2014 Nov; 34(6):660-8. PubMed ID: 25498384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on renal osteodystrophy: pathogenesis and clinical management.
    Sakhaee K; Gonzalez GB
    Am J Med Sci; 1999 Apr; 317(4):251-60. PubMed ID: 10210362
    [No Abstract]   [Full Text] [Related]  

  • 30. [Renal osteodystrophy: role of vitamin D and parathyroid hormone].
    Drüeke T; Ulmann A
    Nouv Presse Med; 1979 May; 8(23):1901-3. PubMed ID: 223122
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal osteodystrophy in dialyzed children.
    Salusky IB; Goodman WG
    Miner Electrolyte Metab; 1991; 17(4):273-80. PubMed ID: 1813790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal osteodystrophy in children with end-stage kidney failure.
    Chan JC
    Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal osteodystrophy and secondary hyperparathyroidism].
    Zhu J
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):150. PubMed ID: 7648931
    [No Abstract]   [Full Text] [Related]  

  • 34. Secondary hyperparathyroidism in chronic renal failure.
    Wills MR; Savory J
    Ann Clin Lab Sci; 1981; 11(3):252-61. PubMed ID: 6264838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bone disease in patients with chronic renal failure and during long-term hemodialysis].
    Flury W
    Ther Umsch; 1972 Sep; 29(9):554-9. PubMed ID: 4628712
    [No Abstract]   [Full Text] [Related]  

  • 36. 1,25 (OH)2 vitamin D3 deficiency and renal osteodystrophy: should its well-accepted pathogenetic role in secondary hyperparathyroidism lead to its systematic preventive therapeutic use?
    Fournier A; Moriniere P; Boudaillez B; Renaud H; Marie A; Westeel PF; Hocine C; Belbrik S
    Nephrol Dial Transplant; 1987; 2(6):498-503. PubMed ID: 3126450
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent advances in the management of renal osteodystrophy in children.
    Salusky IB; Ramirez JA; Goodman WG
    Curr Opin Nephrol Hypertens; 1993 Jul; 2(4):580-7. PubMed ID: 7859020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mineral and bone disorder in chronic kidney disease].
    Matuszkiewicz-Rowińska J; Kulicki P
    Wiad Lek; 2014; 67(3):419-21. PubMed ID: 25782203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mechanism of uremic osteodystrophy and prevention of hyperparathyroidism in the uremic patient].
    Brancaccio D; Cozzolino M; Galassi A; Bellasi A; Carpani P; Gallieni M
    G Ital Nefrol; 2003; 20 Suppl 22():S12-6. PubMed ID: 12851915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal osteodystrophy: review of the disease and its treatment.
    El-Kishawi AM; El-Nahas AM
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):373-82. PubMed ID: 16970258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.